logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Haier Smart Home (06690.HK) spent 3.323 million yuan to repurchase 127,800 A-shares on May 15th.

date
16/05/2025
Zhijie Finance and Economics APP news, Haier Smart Home (06690.HK) announced that on May 15, 2025, the company spent 3.323 million yuan to repurchase 127,800 A-shares.
Latest
3 m ago
Deutsche Bank proposes a dividend of 0.68 euros per share.
3 m ago
Deutsche Bank proposes a dividend of 0.68 per share.
4 m ago
The Wall Street Journal reported that the US Department of Justice has started a criminal investigation into UnitedHealth Group for possible healthcare insurance fraud, causing the company's stock price to plummet nearly 13% on Thursday. Since reaching a historic high in November last year, the market value of this healthcare group has decreased by more than half, over $300 billion. UnitedHealth stock fell to $267 per share in midday trading, nearing a five-year low. It is the worst performing Dow component so far this year.
4 m ago
Criminal investigation report exacerbates investor concerns, United Health plunges.
8 m ago
Guggenheim: Maintains Buy rating on Cabaletta Bio (CABA.US), adjusted from Buy to Buy rating, target price adjusted from $23.00 to $25.00.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.